Skip to content

Biohaven BHVN Accounts Payable

Accounts Payable at other companies

Eli Lilly logo
Eli LillyLLY
$5.03B+46.1%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$38.25M+24.8%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$6.56M+207%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$5.45M+46.2%
uniQure logo
uniQureQURE
$4.4M-16.5%
Roivant Sciences logo
Roivant SciencesROIV
$18M-24.0%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's accounts payable?
Biohaven (BHVN) reported accounts payable of $10.42M in Q1 2026.
How has Biohaven's accounts payable changed year-over-year?
Biohaven's accounts payable decreased by 45.6% year-over-year, from $19.14M to $10.42M.
What is the long-term trend for Biohaven's accounts payable?
Over 4 years (2021 to 2025), Biohaven's accounts payable has grown at a 87.1% compound annual growth rate (CAGR), from $5.54M to $67.9M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.